CALCITRIOL KP calcitriol 0.25 microgram capsule blister pack

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

calcitriol, Quantity: 0.25 microgram

Verfügbar ab:

Amneal Pharma Australia Pty Ltd

INN (Internationale Bezeichnung):

Calcitriol

Darreichungsform:

Capsule, soft

Zusammensetzung:

Excipient Ingredients: fractionated coconut oil; butylated hydroxyanisole; butylated hydroxytoluene; Gelatin; glycerol; sorbitol solution (70 per cent) (non-crystallising); purified water; iron oxide red; iron oxide yellow; titanium dioxide

Verabreichungsweg:

Oral

Einheiten im Paket:

100 capsules

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

Calcitriol KP is indicated for the treatment of established osteoporosis diagnosed by objective measuring techniques, such as densitometry, or by radiographic evidence of atraumatic fracture.,Calcitriol KP is also indicated for the prevention of corticosteroid-induced osteoporosis in patients commencing oral steroid therapy in a dose and regimen expected to result in a significant bone loss.,Calcitriol KP is indicated in the treatment of hypocalcemia in patients with uremic osteodystrophy, hypoparathyroidism and in hypophosphataemic rickets.

Produktbesonderheiten:

Visual Identification: Red coloured, oval soft gelatin capsules containing a clear oily liquid.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2015-12-01